Evidence map›Paper›PMID 32968388›Full record

ArticlePakistan journal of medical sciences

Emerging Anti-Microbial Resistance in Febrile Neutropenia: Is it high time to evaluate quality control measures?

Uzma Mahar, Nida Anwar, Naveena Fatima, Jawad Hassan, Tahir Shamsi

Open access · goldAbstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Uzma MaharUzma Mahar, (FCPS Resident) Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
Nida AnwarNida Anwar, (FCPS), Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
Naveena FatimaNaveena Fatima, (Pharm -D) Department of Research and Development, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
Jawad HassanJawad Hassan, (FCPS) Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
Tahir ShamsiTahir Shamsi, (FRCPath) Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
National Institute Of Blood Disease and Bone Marrow Transplantation · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe performed a prospective analysis at our center to find out the most common organisms causing bacterial infections to establish pattern of antibiotic resistance, in order to combat febrile neutropenia effectively in the terms of outcome as well as cost.

methodsA hospital based observational study was conducted at National Institute of Blood Diseases and bone marrow transplantation from January 2017 to December 2017. Patients presented with absolute neutrophil count (ANC) of less than 500/ml were enrolled. Data were analyzed by SPSS version 21.0. P value of <0.05 was considered statistically significant.

resultsIn this study, a total of 242 patients from various hematological disorders were enrolled and 403 bacterial isolates were obtained. The most frequent isolated gram-negative organisms were

conclusionThe choice of empirical antibiotic regimen should be based on local spectrum of bacteria and their regional susceptibility pattern to improve the survival and minimize hospital stay of patients.

Indexed as

Anti-Microbial ResistanceFebrile NeutropeniaQuality Control

Identifiers

PMID32968388
PMCPMC7501026
OpenAlexW3044411395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.